Vulnerability Monitor

The vendors, products, and vulnerabilities you care about

CVE-2004-2030

Multiple cross-site scripting (XSS) vulnerabilities in index.jsp for Liferay before 2.2.0 release 10/1/2004 allow remote attackers to inject arbitrary web script or HTML, as demonstrated using the message subject.

Security Impact Summary

CVE-2004-2030 is a security vulnerability that . Impacting 1 product from liferay organizations running these solutions should prioritize assessment and patching.

Historical Context

Originally identified in 2004, this vulnerability predates many modern security frameworks and practices. The vulnerability landscape of that era was characterized by different threat models and less mature defense mechanisms compared to contemporary standards.

Published

2004-05-22T04:00:00.000

Last Modified

2025-04-03T01:03:51.193

Status

Deferred

Source

[email protected]

Severity

CVSSv2: 4.3 (MEDIUM)

CVSSv2 Vector

AV:N/AC:M/Au:N/C:N/I:P/A:N

Access Vector: NETWORK
Access Complexity: MEDIUM
Authentication: NONE
Confidentiality Impact: NONE
Integrity Impact: PARTIAL
Availability Impact: NONE

Exploitability Score

8.6

Impact Score

2.9

Weaknesses

Type: Primary
CWE-79

Affected Vendors & Products

Type	Vendor	Product	Version/Range	Vulnerable?
Application	liferay	liferay_enterprise_portal	≤ 2.1.1	Yes
Application	liferay	liferay_enterprise_portal	2.1.0	Yes

References

http://marc.info/?l=bugtraq&m=108526683823840&w=2 ([email protected])
http://marc.info/?l=bugtraq&m=110141194202856&w=2 ([email protected])
http://secunia.com/advisories/11692 Vendor Advisory ([email protected])
http://securitytracker.com/id?1010259 ([email protected])
http://sourceforge.net/project/shownotes.php?release_id=252060 ([email protected])
http://www.osvdb.org/6346 Patch, Vendor Advisory ([email protected])
http://www.securityfocus.com/bid/10402 Patch, Vendor Advisory ([email protected])
https://exchange.xforce.ibmcloud.com/vulnerabilities/16232 ([email protected])
http://marc.info/?l=bugtraq&m=108526683823840&w=2 (af854a3a-2127-422b-91ae-364da2661108)
http://marc.info/?l=bugtraq&m=110141194202856&w=2 (af854a3a-2127-422b-91ae-364da2661108)
http://secunia.com/advisories/11692 Vendor Advisory (af854a3a-2127-422b-91ae-364da2661108)
http://securitytracker.com/id?1010259 (af854a3a-2127-422b-91ae-364da2661108)
http://sourceforge.net/project/shownotes.php?release_id=252060 (af854a3a-2127-422b-91ae-364da2661108)
http://www.osvdb.org/6346 Patch, Vendor Advisory (af854a3a-2127-422b-91ae-364da2661108)
http://www.securityfocus.com/bid/10402 Patch, Vendor Advisory (af854a3a-2127-422b-91ae-364da2661108)
https://exchange.xforce.ibmcloud.com/vulnerabilities/16232 (af854a3a-2127-422b-91ae-364da2661108)

How SecUtils Interprets This CVE

SecUtils normalizes and enriches National Vulnerability Database (NVD) records by standardizing vendor and product identifiers, aggregating vulnerability metadata from both NVD and MITRE sources, and providing structured context for security teams. For liferay's affected products, we extract Common Platform Enumeration (CPE) data, Common Weakness Enumeration (CWE) classifications, CVSS severity metrics, and reference data to enable rapid vulnerability prioritization and asset correlation. This record contains no exploit code, proof-of-concept instructions, or attack methodologies—only defensive intelligence necessary for patch management, risk assessment, and security operations.